Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in outcomes following whole blood transfusion for patients with severe hemorrhage.

The journal of trauma and acute care surgery·2026
Same author

Association of hospital volume with perioperative and long-term outcomes of minimally invasive thymectomy.

JTCVS open·2026
Same author

Narrative review of the ethics of artificial intelligence: are we ready for artificial intelligence in surgery?

Journal of thoracic disease·2026
Same author

Association of decreased lymphatic vessel density with postoperative eyelid edema.

Frontiers in ophthalmology·2026
Same author

The INI-32 dataset: An annotated computed tomography atlas of the orbit.

Data in brief·2025
Same author

The ethics of buy-in before transplantation.

Current opinion in organ transplantation·2025

Related Experiment Video

Updated: Jun 21, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K

Giant Cell Arteritis: Updates and Controversies.

Erin Yu1, Jessica R Chang1

  • 1University of Southern California Roski Eye Institute, Keck School of Medicine of USC, Los Angeles, CA, United States.

Frontiers in Ophthalmology
|July 10, 2024
PubMed
Summary

Giant cell arteritis (GCA) is a vasculitis affecting large arteries, often presenting with vision loss. Diagnosis involves clinical findings, imaging, and sometimes biopsy, with corticosteroids and steroid-sparing agents used for treatment.

Keywords:
MRI black bloodarteritic anterior ischemic optic neuropathy (AAION)epidemiologygiant cell arteritis (GCA)temporal artery biopsyvasculitis

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

68
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

572

Related Experiment Videos

Last Updated: Jun 21, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

68
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

572

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Immunology

Background:

  • Giant cell arteritis (GCA) is a systemic granulomatous vasculitis impacting medium and large arteries.
  • Ophthalmic manifestations are common and can lead to vision loss.
  • GCA epidemiology shows variation across ethnic groups and increasing recognition in minority populations.

Purpose of the Study:

  • To review the epidemiology, pathophysiology, clinical presentation, diagnostic workup, and treatment of GCA.
  • To highlight the ophthalmic manifestations and diagnostic challenges.
  • To discuss current and emerging treatment strategies.

Main Methods:

  • Literature review of GCA epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment.
  • Analysis of diagnostic modalities including temporal artery biopsy, ultrasound, MRI, and PET CT.
  • Review of current treatment standards and novel therapeutic agents.

Main Results:

  • GCA affects the elderly, with potential underdiagnosis in African Americans and Hispanics.
  • Arteritic anterior ischemic optic neuropathy is the most frequent ophthalmic issue.
  • Temporal artery biopsy is standard, but ultrasound shows promise; corticosteroids are primary treatment, with tocilizumab as a steroid-sparing option.

Conclusions:

  • GCA diagnosis requires a combination of clinical suspicion, supportive tests, and imaging.
  • Prompt treatment with corticosteroids is crucial to prevent vision loss.
  • Steroid-sparing agents like tocilizumab offer alternatives to mitigate corticosteroid side effects.